FTC Says Impax Must Sell 10 Generics After Amneal Deal
Six months after generics giant Impax Laboratories Inc. agreed to combine with privately held Amneal Pharmaceuticals LLC, the Federal Trade Commission announced Friday that it is requiring Impax to divest rights...To view the full article, register now.
Already a subscriber? Click here to view full article